Published in Thromb Haemost on April 30, 1978
Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin. Br J Pharmacol (1982) 2.01
Responses of human, monkey and dog coronary arteries in vitro to carbocyclic thromboxane A2 and vasodilators. Br J Pharmacol (1984) 0.94
Increased prostacyclin and thromboxane A2 biosynthesis in atherosclerosis. Proc Natl Acad Sci U S A (1988) 0.92
Immunoelectrophoretic and immunohistochemical characterizations of fibrinogen derivatives in atherosclerotic aortic intimas and vascular prosthesis pseudo-intimas. Am J Pathol (1992) 0.83
Coronary artery spasm: a review. J R Soc Med (1980) 0.80
Nobel lecture. Adventures and excursions in bioassay--the stepping stones to prostacyclin. Postgrad Med J (1983) 0.79
Nobel lecture, 8th December 1982. Adventures and excursions in bioassay: the stepping stones to prostacyclin. Br J Pharmacol (1983) 0.78
Influence of hypercholesterolemia and cholesterol accumulation on rabbit carrageenan granuloma macrophage activation. Am J Pathol (1988) 0.76
Development of optimal infusion regimens for epoprostenol using radio labelled platelet uptake over atherosclerotic lesions in man. Br J Clin Pharmacol (1987) 0.75
Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet (2001) 6.38
Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest (1983) 3.47
Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity? Lancet (1978) 3.15
Moderate alcohol use and health: a consensus document. Nutr Metab Cardiovasc Dis (2013) 2.77
Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol (2004) 2.02
Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events. Lab Invest (1982) 1.90
In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products. Arterioscler Thromb Vasc Biol (2001) 1.88
Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding. J Clin Invest (1985) 1.79
Pimozide therapy for trigeminal neuralgia. Arch Neurol (1989) 1.56
Evidence that vascular endothelial cells can induce the retraction of fibrin clots. Proc Soc Exp Biol Med (1981) 1.51
Difference in direct charge-parity violation between charged and neutral B meson decays. Nature (2008) 1.46
Prostacyclin and human foetal circulation. Prostaglandins (1979) 1.42
Homocysteine levels are associated with the severity of peripheral arterial disease in Type 2 diabetic patients. J Thromb Haemost (2003) 1.42
Effect of house dust mite avoidance measures in children with atopic dermatitis. Br J Dermatol (2000) 1.42
Cancer cell procoagulant activity: evaluation by an amidolytic assay. Thromb Res (1980) 1.41
The PLAT Study: a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients. Atherosclerosis (1991) 1.40
Inverse relationships between haemoglobin and ristocetin-induced platelet aggregation in haemodialysis patients under erythropoietin therapy. Nephrol Dial Transplant (1996) 1.40
Clinical efficacy and safety of cisapride and clebopride in the management of chronic functional dyspepsia: a double-blind, randomized study. Ital J Gastroenterol (1991) 1.39
Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients. Transplant Proc (2009) 1.35
Rapid increase in the incidence of type 1 diabetes in Polish children from 1989 to 2004, and predictions for 2010 to 2025. Diabetologia (2010) 1.35
Congenital absence of the internal carotid artery. Cardiovasc Intervent Radiol (1999) 1.33
Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsia. Prostaglandins (1980) 1.33
Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation. J Thromb Haemost (2006) 1.30
Osteochondroma of the L-5 vertebra: a rare cause of sciatic pain. Case report. J Neurosurg (1999) 1.29
Uraemic bleeding: role of anaemia and beneficial effect of red cell transfusions. Lancet (1982) 1.27
Bleeding time in laboratory animals. II - A comparison of different assay conditions in rats. Thromb Res (1979) 1.26
Relation of the -174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. Am J Cardiol (2001) 1.21
Pathogenesis of thrombosis in patients with malignancy. Int J Hematol (2001) 1.18
Platelet/polymorphonuclear leukocyte adhesion: a new role for SRC kinases in Mac-1 adhesive function triggered by P-selectin. Blood (2001) 1.17
Direct induction of tissue factor synthesis by endotoxin in human macrophages from diverse anatomical sites. Immunology (1983) 1.15
Dietary patterns, cardiovascular risk factors and C-reactive protein in a healthy Italian population. Nutr Metab Cardiovasc Dis (2009) 1.15
Could neutrophil-gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values? Kidney Blood Press Res (2007) 1.15
Blood coagulation changes in mice bearing Lewis lung carcinoma, a metastasizing tumor. Cancer Res (1977) 1.14
Platelet hyperaggregability and the nephrotic syndrome. Thromb Res (1979) 1.12
Comparison of glacial and non-glacial-fed streams to evaluate the loading of persistent organic pollutants through seasonal snow/ice melt. Chemosphere (2008) 1.11
Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues. Blood (1983) 1.10
Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br J Pharmacol (1998) 1.09
Bleeding time in laboratory animals. III - Do tail bleeding times in rats only measure a platelet defect? (the aspirin puzzle). Thromb Res (1979) 1.09
A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation. Cancer (1998) 1.08
Evidence that cells from experimental tumours can activate coagulation factor X. Br J Cancer (1979) 1.07
Platelet glycoprotein receptor IIIa polymorphism PLA1/PLA2 and coronary risk: a meta-analysis. Thromb Haemost (2001) 1.07
Bleeding time in rats: a comparison of different experimental conditions. Thromb Haemost (1982) 1.05
Familial deficiency of a plasma factor stimulating vascular prostacyclin activity. Thromb Res (1979) 1.05
Inhibition of thromboxane synthetase does not necessarily prevent platelet aggregation. Lancet (1981) 1.05
Malignancy and haemostasis. Br J Haematol (1980) 1.04
Hemobilia, intrahepatic hematoma and acute thrombosis with cavernomatous transformation of the portal vein after percutaneous thermoablation of a liver metastasis. Eur Radiol (2000) 1.04
Polymorphonuclear leukocyte-platelet interaction: role of P-selectin in thromboxane B2 and leukotriene C4 cooperative synthesis. Thromb Haemost (1994) 1.03
Interferon inhibits prostaglandin biosynthesis in macrophages: effects on arachidonic acid metabolism. J Immunol (1984) 1.02
Observation of anomalous upsilon(1S)pi+pi(-) and upsilon(2S)pi+pi(-) production near the upsilon(5S) resonance. Phys Rev Lett (2008) 1.02
Cisplatin (P) versus cyclophosphamide, adriamycin and cisplatin (CAP) for stage III-IV epithelial ovarian carcinoma: a prospective randomized trial. Tumori (1988) 1.02
The -675 4G/5G plasminogen activator inhibitor-1 promoter polymorphism in house dust mite-sensitive allergic asthma patients. Allergy (2006) 1.01
Indomethacin and urinary excretion of fibrinogen-like material in proliferative glomerulonephritis. Rev Eur Etud Clin Biol (1970) 1.00
Treatment of the hemolytic uremic syndrome with plasma. Clin Nephrol (1979) 0.99
Congenital developmental arrest of the lung. Ann Thorac Surg (1970) 0.99
Typical breakfast food consumption and risk factors for cardiovascular disease in a large sample of Italian adults. Nutr Metab Cardiovasc Dis (2010) 0.98
The t(4;8) is mediated by homologous recombination between olfactory receptor gene clusters, but other 4p16 translocations occur at random. Genet Couns (2007) 0.98
Leptin induces tissue factor expression in human peripheral blood mononuclear cells: a possible link between obesity and cardiovascular risk? J Thromb Haemost (2007) 0.98
Neonatal transfusions. Vox Sang (2009) 0.97
Opposite membrane potential changes induced by glucose deprivation in striatal spiny neurons and in large aspiny interneurons. J Neurosci (1997) 0.97
Cannabinoid CB1-mediated inhibition of stress-induced gastric ulcers in rats. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.96
Immunolocalization of CB1 receptor in rat striatal neurons: a confocal microscopy study. Synapse (2004) 0.96
Specific binding of human fibrinogen to cultured human fibroblasts. Evidence for the involvement of the E domain. Eur J Biochem (1984) 0.96
Normal prostacyclin-like activity in vascular tissues from thrombocytopenic rats. Thromb Res (1977) 0.95
A new procoagulant in acute leukemia. Blood (1988) 0.95
Platelet-aggregating activity in neuraminidase-treated human cryoprecipitates: its correlation with factor-VIII-related antigen. Br J Haematol (1974) 0.95
Aggregation of human platelets by bovine or human factor VIII: role of carbohydrate side chains. Nature (1973) 0.95
Bleeding in renal failure: altered platelet function in chronic uraemia only partially corrected by haemodialysis. Nephron (1978) 0.95
Unbalanced prostaglandin synthesis and plasma factors in uraemic bleeding. A hypothesis. Thromb Res (1978) 0.95
Aspirin, thromboxane, and prostacyclin in rats: A dilemma resolved? Lancet (1978) 0.94
Type 2 diabetes and polymorphisms on chromosome 9p21: a meta-analysis. Nutr Metab Cardiovasc Dis (2011) 0.94
Prostaglandins as inhibitors of human platelet aggregation. Br J Haematol (1979) 0.94
Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group. Arterioscler Thromb (1993) 0.93
Salicylate reverses in vitro aspirin inhibition of rat platelet and vascular prostaglandin generation. Biochem Pharmacol (1980) 0.93
Characterization of the response of human thymocytes and blood lymphocytes to the synergistic mitogenicity of 12-O-tetradecanoylphorbol-13-acetate (TPA)-ionomycin. Eur J Immunol (1984) 0.93
The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group. Arterioscler Thromb (1992) 0.92
Prevalence of monogenic diabetes amongst Polish children after a nationwide genetic screening campaign. Diabetologia (2012) 0.92
Cancer procoagulant in human tumor cells: evidence from melanoma patients. Cancer Res (1986) 0.92
Effects of any epoxymethano stable analogue of prostaglandin endoperoxides (U-46619) on human platelets. Thromb Haemost (1981) 0.92
Antithrombotic properties of dermatan sulphate in a rat venous thrombosis model. Haemostasis (1987) 0.92
Visfatin and apelin, new adipocytokines, and their relation to endothelial function in patients with chronic renal failure. Adv Med Sci (2008) 0.92
Accumulation of toxic products degradation of kynurenine in hemodialyzed patients. Int Urol Nephrol (2001) 0.92